IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,880,467 | +2.4% | 961,088 | +18.3% | 0.01% | 0.0% |
Q2 2023 | $48,724,816 | +23.7% | 812,622 | +2.0% | 0.01% | +25.0% |
Q1 2023 | $39,378,515 | +94.5% | 796,491 | +124.5% | 0.00% | +100.0% |
Q4 2022 | $20,243,984 | +188.0% | 354,722 | +136.9% | 0.00% | +100.0% |
Q3 2022 | $7,029,000 | +707.0% | 149,750 | +541.4% | 0.00% | – |
Q2 2022 | $871,000 | +1144.3% | 23,347 | +892.6% | 0.00% | – |
Q1 2022 | $70,000 | +45.8% | 2,352 | +67.4% | 0.00% | – |
Q4 2021 | $48,000 | -44.2% | 1,405 | -39.5% | 0.00% | – |
Q3 2021 | $86,000 | +8500.0% | 2,321 | +11505.0% | 0.00% | – |
Q2 2021 | $1,000 | -99.8% | 20 | -99.9% | 0.00% | – |
Q1 2021 | $648,000 | – | 15,207 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |